Nordicus Partners Corporation (NORD)
OTCMKTS · Delayed Price · Currency is USD
4.050
-0.500 (-10.99%)
Jan 20, 2026, 1:22 PM EST
Nordicus Partners Revenue
Nordicus Partners had revenue of $2.50K in the twelve months ending September 30, 2025, down -50.00% year-over-year. In the fiscal year ending March 31, 2025, Nordicus Partners had annual revenue of $5.00K with 100.00% growth.
Revenue (ttm)
2.50K
Revenue Growth
-50.00%
P/S Ratio
30,313.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.00K | 2.50K | 100.00% |
| Mar 31, 2024 | 2.50K | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karbon-X | 38.70M |
| Entrepreneur Universe Bright Group | 4.40M |
| Meridian Holdings | 1.46M |
| HPN Holdings | 721.92K |
| SSHT S&T Group | 256.99K |
| Global AI | 144.93K |
| AI Metaverse Holdings | 83.70K |
| VizConnect | 7.96K |
Nordicus Partners News
- 2 months ago - NoviThera has initiated the first efficacy animal studies - GlobeNewsWire
- 3 months ago - Orocidin's QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats. - GlobeNewsWire
- 3 months ago - Orocidin develops novel cGMP manufacturing process in collaboration with Syngene - GlobeNewsWire
- 3 months ago - Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS - GlobeNewsWire
- 5 months ago - Nordicus Partners Corporation Applies to Uplist to the Nasdaq Capital Market - GlobeNewsWire
- 5 months ago - Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors - GlobeNewsWire
- 9 months ago - Nord Anglia Education's collaboration with IMG Academy creates exciting new opportunities for student performance, leadership, and wellbeing - Benzinga
- 10 months ago - Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia - GlobeNewsWire